Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.
December 20, 2022 09:42 ET | Revium Recovery, Inc.
New York, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Revium Recovery, Inc. (OTC Pink: RVRC) or ("RVRC) has entered into a non-binding letter of intent to acquire LipoVac, Ltd. ("LipoVac"), a privately...
Hebrew University to Collaborate with Cytovia Therapeutics
March 18, 2020 09:00 ET | Cytovia Therapeutics
NEW YORK and JERUSALEM, March 18, 2020 (GLOBE NEWSWIRE) -- Yissum, the technology transfer company of The Hebrew University of Jerusalem and Cytovia Therapeutics, Inc, a biopharmaceutical company...
NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic
December 16, 2019 08:07 ET | NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on stem-cell-based diagnostic technology to...
Hollywood Media Comp
Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance
July 16, 2018 01:00 ET | Hollywood Media Corp.
Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.Appoints New Board of Directors Led by Jan Loeb as ChairmanForms New Leadership Team with Deep Healthcare ExpertisePlans...